We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...

Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously ...

Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...

Deerfield-based Baxter International is still feeling battered by Hurricane Helene and problems with its Novum infusion pumps ...

Shares of Baxter International Inc. slipped 3.37% to $28.70 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.33% to 6,259.75 and ...

Baxter International BAX 1.10% is selling its kidney care segment to Carlyle CG 2.06% Group for $3.8 billion, most of which will be paid in cash. The Deerfield, Ill., medical-device maker on ...

Baxter International Inc. (NYSE: BAX) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Joe Almeida - Chairman, Chief Executive Officer Joel Grade - Executive Vice ...

Baxter International Inc. closed 30.72% below its 52-week high of $40.49, which the company achieved on September 17th.

The stock's fall snapped a four-day winning streak.